10 results
P
adult patients with COVID-19
I/C
systematic review and meta-analysis of studies published between January 1, 2020, and March 25, 2020, patients with severe clinical course vs. good clinical course
O
frequency of GI and hepatic manifestations, association of GI and hepatic factors with severe clinical course
P
COVID-19 patients
I/C
Integrated Traditional Chinese and Western Medicine (Hereinafter referred to as 'Integrated Medicine'), Control group
O
overall response rate, cure rate, severity illness rate, hospital stay, disappearance rate of fever, cough, expectoration, fatigue, chest tightness, anorexia, fever time, fatigue time
P
patients with COVID-19
I/C
clinical and epidemiological studies, confirmed cases of COVID-19
O
risk factors of COVID-19
P
hospitalized patients with COVID-19
I/C
IVIG (Intravenous Immunoglobulin) therapy, control group
O
mortality
P
subjects
I/C
influenza vaccines, no intervention
O
SARS-CoV-2 infection, severe outcomes
P
patients with newly diagnosed advanced high-grade serous and endometrioid epithelial ovarian cancer (EOC)
I/C
poly(ADP-ribose) polymerase inhibitors (PARPi), placebo
O
progression-free survival (PFS)
P
hospitalized patients with COVID-19 in China
I/C
smoking status, population smoking prevalence in China
O
prevalence of current smoking among hospitalized patients with COVID-19
P
68 260 participants
I/C
meal or gathering, transportation, medical care, work or study places, household, public places, daily conversation
O
secondary attack rates (SARs) of COVID-19
P
pregnant mothers
I/C
COVID-19 infection, mothers without COVID-19 diseases
O
preeclampsia/eclampsia, foetal distress, caesarean section, postpartum haemorrhage, ICU/high-dependency unit admission, preterm births, perinatal death, maternal death rate
P
hip fracture patients
I/C
COVID-19 infection, non-infected patients
O
30-day mortality, inpatient mortality, critical care admission, readmission rate, complications rate